Patient Data Exhibits Review history. Which 2 drugs would be the most appropriate to give the client now?

Rationale: A. Budesonide via metered dose inhaler: Budesonide is an inhaled corticosteroid that reduces airway inflammation but does not work rapidly enough to relieve acute asthma symptoms. It is best suited for long-term control, not immediate rescue in an exacerbation. B. Salmeterol via nebulizer: Salmeterol is a long-acting beta-2 agonist (LABA). It provides prolonged bronchodilation but has a slow onset, making it inappropriate for acute bronchospasm. It should not be used as a rescue therapy. C. Levalbuterol inhaler: Levalbuterol is a short-acting beta-2 agonist (SABA) that quickly relaxes bronchial smooth muscles, improving airflow during an acute asthma attack. It is effective for rapid symptom relief in this client’s presentation of wheezing and tachypnea. D. Fexofenadine orally: Fexofenadine is an oral antihistamine used for allergic rhinitis. It does not address acute airway narrowing or bronchospasm, so it is not useful in an acute asthma exacerbation. E. Racemic epinephrine via nebulizer: Racemic epinephrine is generally used in upper airway obstruction such as croup or stridor. It is not the standard treatment for acute asthma exacerbations. F. Albuterol via nebulizer: Albuterol is the primary rescue medication for acute asthma. It acts rapidly to dilate the bronchi and relieve wheezing and shortness of breath, making it highly appropriate for immediate treatment.